ArticleScientific reports2025

NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model.

Yee Peng Phoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.